Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
34,889,466
-
Shares change
-
+3,373,805
-
Total reported value, excl. options
-
$5,872,673,076
-
Value change
-
+$601,323,211
-
Put/Call ratio
-
107%
-
Number of buys
-
123
-
Number of sells
-
-112
-
Price
-
$168.37
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2015
288 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q2 2015.
BLUEBIRD BIO INC - COM (BLUE) has 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,889,466 shares
.
Largest 10 shareholders include FMR LLC (5,365,592 shares), Capital Research Global Investors (4,381,900 shares), BAILLIE GIFFORD & CO (3,697,412 shares), VANGUARD GROUP INC (2,075,365 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,791,241 shares), Capital World Investors (1,358,000 shares), ORBIMED ADVISORS LLC (958,300 shares), BlackRock Institutional Trust Company, N.A. (745,061 shares), FRANKLIN RESOURCES INC (702,001 shares), and OPPENHEIMER FUNDS INC (688,350 shares).
This table shows the top 234 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.